Announcement

Prescription

Canada’s Plan to Optimize Prescription Drug Use


Canada’s Drug Agency (CDA-AMC) has introduced a comprehensive five-year plan, A Prescription for Action: A Pan-Canadian Strategy for Advancing the Appropriate Use of Prescription Medications, aimed at enhancing the safe and effective use of prescription...

Semaglutide

Novo Nordisk Lawsuits Target Semaglutide Copies


Danish pharmaceutical giant Novo Nordisk has intensified its legal battle against the sale of unapproved versions of semaglutide, the key ingredient in its blockbuster weight-loss and diabetes drugs

Multiple Sclerosis

Breakthrough Treatment Offers Hope for Progressive Multiple Sclerosis


A groundbreaking study, published in the New England Journal of Medicine and led by Dr. Jiwon Oh, a neurologist and scientist at St. Michael’s Hospital, part of Unity Health Toronto, reveals that a new drug,...

Decongestant

Avoid These Mistakes While Taking a Decongestant


A stuffy nose from a cold, flu, or allergies can be bothersome, but over-the-counter (OTC) decongestants like pseudoephedrine (Sudafed), phenylephrine (Sudafed PE, Neo-Synephrine), and oxymetazoline (Afrin) offer quick relief. However, improper use can lead to...

Doctors

Canada’s Barriers for Global Doctors During Health Crisis


Canada faces a critical shortage of family physicians, with approximately six million Canadians lacking access to one. Despite this, internationally trained doctors—known as international medical graduates (IMGs)—are underutilized due to systemic barriers in the licensing...

diabetes

Newly Named Type 5 Diabetes Unveiled


In a landmark decision, the International Diabetes Federation (IDF) officially recognized malnutrition-related diabetes as "Type 5 diabetes" during its World Diabetes Congress in Bangkok, Thailand, on April 8, 2025. This recognition marks a significant step...

Tariffs

Canadian Pharma Faces Uncertainty with US Tariffs


The recent announcement by President Donald Trump regarding the imposition of a 25% tariff on all imported goods, including pharmaceuticals, has raised significant concerns within the Canadian pharmaceutical manufacturing industry.